Detalhe da pesquisa
1.
Neutralizing antibody response after immunization with a COVID-19 bivalent vaccine: Insights to the future.
J Med Virol
; 96(2): e29416, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38285457
2.
SARS-CoV-2 isolation from the first reported patients in Brazil and establishment of a coordinated task network.
Mem Inst Oswaldo Cruz
; 115: e200342, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33111751
3.
Immune Evasion of SARS-CoV-2 Omicron Subvariants XBB.1.5, XBB.1.16 and EG.5.1 in a Cohort of Older Adults after ChAdOx1-S Vaccination and BA.4/5 Bivalent Booster.
Vaccines (Basel)
; 12(2)2024 Jan 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38400128
4.
Dermatological Manifestations in COVID-19: A Case Study of SARS-CoV-2 Infection in a Genetic Thrombophilic Patient with Mthfr Mutation.
Pathogens
; 12(3)2023 Mar 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36986360
5.
Assessment of the Interferon-Lambda-3 Polymorphism in the Antibody Response to COVID-19 in Older Adults Seropositive for CMV.
Vaccines (Basel)
; 11(2)2023 Feb 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36851357
6.
Salivary, serological, and cellular immune response to the CoronaVac vaccine in health care workers with or without previous COVID-19.
Sci Rep
; 12(1): 10125, 2022 06 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35710573